Ranolazine is used to treat chronic angina (chest pain). This medicine is usually used together with other medicines eg, ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, nitrates, antiplatelets, or lipid-lowering medicines. It is grouped under the following drug class(es): Antianginals. Its therapeutic use is listed as angina and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ranexa, Ranolazina and Latixa. Its PubChem CID is 56959.
Ranolazine
| CAS No | 95635-55-5 |
|---|---|
| Molecular Formula | C24H33N3O4 |
| Molecular Weight | 427.5 g/mol |
| Synonyms | N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ranolazine is used to treat chronic angina (chest pain). This medicine is usually used together with other medicines eg, ACE inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, nitrates, antiplatelets, or lipid-lowering medicines.
The listed CAS number is 95635-55-5.
The listed molecular formula is C24H33N3O4.
The listed molecular weight is 427.5 g/mol.
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide.
The source lists Ranexa, Ranolazina and Latixa.